Category:Template-Class pharmacology articles
 | Administrators: Please do not delete this category as empty! This category may be empty occasionally or even most of the time. |
 FA |  A |  GA | B | C | Start | Stub | FL | List | Category | Disambig | Draft | File | Portal | Project | Redirect | Template | NA | ??? |
| 11 | 0 | 48 | 609 | 1,368 | 4,247 | 7,192 | 1 | 430 | 1,105 | 13 | 25 | 44 | 0 | 23 | 931 | 387 | 27 | 1 |
Pages in category "Template-Class pharmacology articles"
The following 128 pages are in this category, out of approximately 387 total. This list may not reflect recent changes.
(previous page) (next page)P
- Template talk:PAF receptor modulators
- Template talk:Parenteral durations of androgens/anabolic steroids
- Template talk:Parenteral potencies and durations of nonsteroidal estrogens
- Template talk:Parenteral potencies and durations of progestogens
- Template talk:Peripheral vasodilators
- Template talk:Pharmaceutical and biotechnology industry in the United Kingdom
- Template talk:Pharmaceutical companies of China
- Template talk:Pharmaceutical companies of the United States
- Template talk:Pharmaceutical industry by country
- Template talk:Pharmaceutical industry in the United States
- Template talk:Pharmacodynamics of aromatase inhibitors
- Template talk:Pharmacodynamics of progestogens
- Template talk:Pharmacokinetic parameters of progesterone by different routes
- Template talk:Pharmacokinetics of 100 mg per day spironolactone and its metabolites
- Template talk:Pharmacokinetics of long-acting injectable antipsychotics
- Template talk:Pharmacokinetics of progestogens
- Template talk:Pharmacokinetics of three estradiol esters by intramuscular injection
- Template talk:Pharmacological body alteration
- Template talk:Pharmacological properties of major anabolic steroids
- Template talk:Pharmacology
- Template talk:Pharmacology of estrone
- Template talk:Pharmacology-journal-stub
- Template talk:Pharmacomodulation
- Template talk:Pharmacy schools in the United Kingdom
- Template talk:PharmNavFootnote
- Template talk:Phenyltropanes
- Template talk:Pheromones and pherines
- Template talk:Phosphodiesterase inhibitors
- Template talk:Pituitary and hypothalamic hormones and analogues
- Template talk:Plasma estrogen levels after a single dose of conjugated estrogens by different routes
- Template talk:Plasma estrogen levels after a single dose of estradiol by different routes
- Template talk:Plasma levels and binding potential of flutamide and bicalutamide during first week
- Template talk:Potencies and durations of natural estrogens by intramuscular injection
- Template talk:PPAR modulators
- Template talk:Preparations for treatment of wounds and ulcers
- Template talk:Progesterone
- Template talk:Progesterone metabolism
- Template talk:Progesterone receptor modulators
- Template talk:Progestogens and antiprogestogens
- Template talk:Prolactin receptor modulators
- Template talk:Prostanoid signaling modulators
- Template talk:Protein binding and metabolic clearance rates of estrogens
- Template talk:Protein synthesis inhibitor antibiotics
- Template talk:Psychoactive-stub
- Template talk:Psychostimulant addiction
- Template talk:Psychostimulants, agents used for ADHD and nootropics
- Template talk:Published case reports of bicalutamide-associated liver injury
- Template talk:Published case reports of bicalutamide-associated lung toxicity
- Template talk:Purine receptor modulators
R
- Template talk:R from drug trade name
- Template talk:Rabies
- Template talk:Racetams
- Template talk:Recent changes in Pharmacology
- Template talk:Receptor modulators
- Template talk:Regulation of therapeutic goods in the United States
- Template talk:Relative affinities of anabolic steroids and related steroids
- Template talk:Relative affinities of estrogens for steroid hormone receptors and blood proteins
- Template talk:Relative affinities of first-generation nonsteroidal antiandrogens for the androgen receptor
- Template talk:Relative affinities of hydroxyprogesterone and related steroids
- Template talk:Relative affinities of levonorgestrel and metabolites
- Template talk:Relative affinities of nandrolone and related steroids
- Template talk:Relative affinities of nandrolone and related steroids at the androgen receptor
- Template talk:Relative affinities of norethisterone, metabolites, and prodrugs
- Template talk:Relative affinities of noretynodrel, tibolone, and metabolites
- Template talk:Relative affinities of normethandrone and metabolites
- Template talk:Relative androgenic to anabolic activity in animals
- Template talk:Relative oral potencies of estrogens
- Template talk:Relative potencies of selected antiandrogens
- Template talk:Retinoid receptor modulators
- Template talk:Risk factors in CD vs. UC
- Template talk:RNA antivirals
S
- Template talk:Selected biological properties of endogenous estrogens in rats
- Template talk:Serotonin receptor modulators
- Template talk:Sexual dysfunction pharmacotherapies
- Template talk:Side effects of estramustine phosphate (EMC)
- Template talk:Side effects of estramustine phosphate (FDA)
- Template talk:Side effects of estrogen plus high- versus low-dose cyproterone acetate in women
- Template talk:Sigma receptor modulators
- Template talk:Sodium-glucose transporter modulators
- Template talk:Spirolactone structures
- Template talk:Spironolactone
- Template talk:Spironolactone at steroid hormone receptors
- Template talk:Steroid hormones
- Template talk:Stomatological preparations
- Template talk:Structural aspects of androgens and anabolic steroids
- Template talk:Structural aspects of progestogens used in clinical and veterinary medicine
- Template talk:Structural properties of major anabolic steroid esters
- Template talk:Structural properties of major testosterone esters
- Template talk:Structural properties of selected estradiol esters
- Template talk:Sunscreening agents
- Template talk:Sympatholytic antihypertensives
- Template talk:Symporter inhibitors
T
- Template talk:TAAR ligands
- Template talk:Target ranges for hormone levels in hormone therapy for transgender women
- Template talk:Targeted cancer therapeutic agents
- Template talk:Testosterone
- Template talk:Testosterone levels with cyproterone acetate
- Template talk:Testosterone metabolism mini
- Template talk:Tetracyclics
- Template talk:TGFβ receptor superfamily modulators
- Template talk:The Pharmacology Barnstar
- Template talk:Throat preparations
- Template talk:Thyroid hormone receptor modulators
- Template talk:Thyroid therapy
- Template talk:Timothy Leary
- Template talk:Tissue-specific estrogenic and antiestrogenic activity of SERMs
- Template talk:TNF receptor superfamily modulators
- Template talk:Topical products for joint and muscular pain
- Template talk:Transdermal estradiol patches marketed in the United States
- Template talk:Transient receptor potential channel modulators
- Template talk:Translocator protein modulators
- Template talk:Tricyclics
- Template talk:Tryptophan metabolism by human microbiota